EN
HI
Summary
As of 8 Nov, 2026, Thyrocare Technologies stock price is ₹498.95. During the trading session, the stock has moved between an intraday low of ₹493.10 and an intraday high of ₹503.95. Over the last 52 weeks, Thyrocare Technologies has traded between ₹342.55 and ₹1610.00.
The stock has recorded a trading volume of 56,019 shares,. Its Average Traded Price (ATP) is ₹499.69, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 4 @ ₹498.95.
Thyrocare Technologies has an upper circuit limit of ₹591.70 and a lower circuit limit of ₹394.50. The total value traded stands at ₹2.80 CR, and the delivery percentage for the day is 49.62%.
The stock is currently traded with a market lot size of 1. Thyrocare Technologies also offers a dividend yield of 2.86%.
Thyrocare Technologies Share Price Chart
Thyrocare Technologies Share Key Metrics
Volume
56019.00
Market Cap
7941.55 CR
LTQ@LTP
4@498.95
ATP
499.69
Var Margin
20.57 %
Circuit Range
394.5-591.7
Delivery %
49.62 %
Value
2.80 CR
ASM/GSM
No
Market Lot
1
Thyrocare Technologies Fundamentals
P/E Ratio
54.11
P/B Ratio
14.1
Div. Yield
2.86
Sector P/E
56.45
Sector P/B
-13.24
Sec. Div. Yield
0.18
Thyrocare Technologies Resistance and Support
Pivot 491.33
Resistance
First Resistance
498.21
Second Resistance
503.33
Third Resistance
510.21
Support
First Support
486.21
Second Support
479.33
Third Support
474.21
Thyrocare Technologies Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Sun Nov 08 2026 | 500 | 498.95 | 1.19% | 503.95 | 493.1 |
| Fri Nov 06 2026 | 489.75 | 493.1 | 0.68% | 496.45 | 484.45 |
| Thu Nov 05 2026 | 507.89 | 489.75 | -1.16% | 507.89 | 487.7 |
Thyrocare Technologies Corporate Actions
| Date | Agenda |
|---|---|
| 2026-10-29 | Quarterly Results |
| 2026-07-23 | Quarterly Results |
| 2026-05-07 | Audited Results & Final Dividend |
| 2026-01-28 | Quarterly Results |
| 2025-10-14 | Qtr Results |
| 2025-07-23 | Quarterly Results |
| 2025-04-23 | Audited Results & Final Dividend |
| 2025-01-23 | Quarterly Results |
| 2024-10-23 | Quarterly Results |
Thyrocare Technologies News
Thyrocare Technologies Ltd - 539871 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Thyrocare Technologies: Allotment of 1,94,289 equity shares under ESOS approved on Nov 06, 2026.
Nov 06 2026 16:34:59
Thyrocare Technologies Ltd - 539871 - Execution Of Share Purchase Agreement In Relation To The Sale Of The Company'S Entire Shareholding In Nueclear Healthcare Limited, A Wholly Owned Subsidiary Of The Company
Thyrocare has signed a Share Purchase Agreement to sell its material wholly-owned subsidiary, Nueclear Healthcare, to Trovera Healthcare for Rs.141.40 crores. The consideration includes Rs.81.90 crores in cash and Rs.59.50 crores via CCPS of Trovera.
Oct 30 2026 17:28:21
Read More
Thyrocare Technologies Management
| Name | Position |
|---|---|
| Brijesh Kumar | Company Secretary & Compliance Officer |
| Rahul Guha | Chairman, Managing Director & Chief Executive Officer |
Thyrocare Technologies Similar Stocks
Healthcare Global Enterprises Ltd.
599.85
-0.40 (0.07%)
Procter & Gamble Health Ltd.
5716.50
160.50 (2.89%)
Aarti Pharmalabs Ltd.
929.70
0.60 (0.06%)
Paras Healthcare Ltd.
743.00
8.45 (1.15%)
Symbiotec Pharmalab Ltd.
1597.90
84.30 (5.57%)
Suven Life Sciences Ltd.
274.30
9.45 (3.57%)
Sanofi India Ltd.
3301.90
18.80 (0.57%)
Bliss GVS Pharma Ltd.
624.20
9.95 (1.62%)
Kovai Medical Center & Hospital Ltd.
5987.00
38.50 (0.65%)
FDC Ltd.
392.60
2.65 (0.68%)
Thyrocare Technologies FAQs
The Buying Price of Thyrocare Technologies share is 498.95 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Thyrocare Technologies stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Thyrocare Technologies, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Thyrocare Technologies shares is 54.11. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Thyrocare Technologies shares is 14.1. Useful to assess the stock's value relative to its book value.
To assess Thyrocare Technologies’s valuation compare Sector P/E, P/B which are 56.45 & -13.24 with sector averages, along with growth rates and financial metrics.
The Market Cap of Thyrocare Technologies is 7941.55 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Thyrocare Technologies share price is 1610.00 & 342.55. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Thyrocare Technologies belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in THYROCARE
